Asia Pacific Clinical Trial Supplies Market Size & Outlook
Asia Pacific clinical trial supplies market, 2018-2030 (US$M)
Related Markets
Asia Pacific clinical trial supplies market highlights
- The Asia Pacific clinical trial supplies market generated a revenue of USD 438.3 million in 2023.
- The market is expected to grow at a CAGR of 7% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 438.3 million |
| Market revenue in 2030 | USD 704.4 million |
| Growth rate | 7% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 17.0% of the global clinical trial supplies market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 704.4 million by 2030.
Phase iii was the largest segment with a revenue share of 53.52% in 2023. Horizon Databook has segmented the Asia Pacific clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to be one of the fastest growing regions in global clinical trial supplies market. The tremendous growth in clinical research is expected to drive growth of clinical trial supplies market in the region, thereby contributing to the growth of global clinical trial supplies market.
The primary factors driving the growth of clinical research in these regions include low cost per patient in Asia Pacific countries and presence of a diverse group of patients that are easy to recruit. According to a survey by Pharma IQ, 60.0% of the respondents consider China and India as potential regions for clinical research in the next five years.
Entry of Almac Group, a global clinical research and manufacturing organization, in Asia Pacific region is a clear indication of growth of clinical trial supplies market in this region. In 2015, Almac Group announced its new clinical trial supply facility and regional headquarters to serve Asia Pacific clients, as 23.0% of the global clinical trials for new biopharmaceutical products are being conducted in this region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific clinical trial supplies market size, by country, 2018-2030 (US$M)
Asia Pacific Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
